Jazz Pharmaceuticals plc (JAZZ) Revenue 2016–2025
Jazz Pharmaceuticals plc (JAZZ) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$4.3BFY2025 · since FY2016: $1.5B → $4.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.3B | +4.9% |
| FY2024 | $4.1B | +6.1% |
| FY2023 | $3.8B | +4.8% |
| FY2022 | $3.7B | +18.3% |
| FY2021 | $3.1B | +30.9% |
| FY2020 | $2.4B | +9.3% |
| FY2019 | $2.2B | +14.3% |
| FY2018 | $1.9B | +16.8% |
| FY2017 | $1.6B | +8.8% |
| FY2016 | $1.5B | — |
Source: SEC XBRL filings · For reference only · Not investment advice